Research Triangle Park – October 13, 2026 -- IQVIA has selected four Veeva applications (CTMS, eTMF, Study Startup and Site Connect) as enterprise standards for its clinical development studies, extending a partnership that previously covered Veeva's EDC.

IQVIA and Veeva widen the clinical technology tie-up beyond EDC

IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) announced the expansion on Oct. 13, 2026. The companies say the combined offering is intended to raise trial speed and efficiency, strengthen site centricity and improve decision-making.

Pleasanton, Calif. – October 07, 2026 -- More than 175 emerging biotechs have adopted Veeva Basics, a suite of pre-configured, pre-validated applications spanning clinical, regulatory, quality, medical, and commercial functions, Veeva Systems (NYSE: VEEV) announced.

Barcelona – October 06, 2026 -- Veeva Systems (NYSE: VEEV) said its Data Quality System (DQS) has aggregated and cleaned data for more than 1 million subjects across over 1,000 clinical studies, automating over 500,000 queries and eliminating thousands of hours of manual data reconciliation for sites and sponsors.